Looking forward to getting this published and creating a website for colleagues to use LiverTox Liver Fellow Network Michigan Hepatology Michigan Medicine

Back by popular demand! Join us to win a prize and bragging rights 👉Sunday 11/17/24 9:45am Ballroom 6D "We wanted to do something silly, With a nod from AASLD, really! Don’t let this pass by, Or Jim might just cry, Welcome to Wait, Wait, Don’t....." Jim luyendyk AASLD

You don’t need to know each detail Just know prizes may land in your email Whether he knows it or not David Kleiner’s your bot If you win, he records your new….voicemail Also there are coffee mugs. 😁 David Kleiner AASLD See you all at Wait Wait…

Opportunity to connect with friends and colleagues attending AASLD #TLM2024 from across the globe. DILI investigators meet #TLM24 Naga Chalasani Einar S. Björnsson

Packed U.S. FDA corner session at #TLM24 #TLM2024 AASLD

Kudos to Robert Fontana and jonnysexton for pulling off a very successful Hepatotoxicity SIG session on organoids at #tlm2024! Cutting edge tools to study liver disease and DILI! AASLD

🌿 Exciting insights from Dr. Ghabril at the packed @aasldtweets "Wait, Wait...Don't DILI!" session! He discussed emerging causes of Drug-Induced Liver Injury (#DILI), highlighting the role of Withania somnifera (ashwagandha). 💡 #LiverTwitter #TLM24

Raising public awareness one meeting at a time... #DILI was big at #TLM2024

Predicting drug-induced liver injury during drug development will decrease he burden of DILI. Investigators from PLRC are presenting their work on human biomimetic micro physiologic systems at the next AASLD Hepatotoxicity seminar. Registration link here:

We often overlook the hepatotoxicity of environmental toxicants. Timely presentation from Dr. Julianne Beier ArteelBeierLabs on the impact of PFAS, microplastics and organic pollutants on the liver! Register below

Interesting seminar on the effect of environmental toxins on the liver #hepatotoxicity

What makes you tip over from liver injury to ALF? We are honored to host Dr. Bryan Copple tomorrow for the AASLD Hepatotoxicity SIG seminar. Wen-Xing Ding LiverTox To join us register for a link: aasld.zoom.us/meeting/regist…

A very nice review of DILI in patients with underlying CLD.

Early experience with resmetirom to treat MASH by Indiana University Gastroenterology and Hepatology pubmed.ncbi.nlm.nih.gov/40178494/ -High d/c rate due to GI AEs -Need close f/u early to manage GI AEs -Certainly not "prescribe & forget" like DAAs Madrigal Pharmaceuticals Raj VuppaLanchi Naim Alkhouri mazen noureddin Elliot Tapper

DILI harms patients and remains a TOP reason drugs are withdrawn from the market. Recommend this article by Naga Chalasani et al in HEPATOLOGY Journal reviewing preclinical and clinical testing, DILI adjudication during trials, and how regulators approach NDAs. journals.lww.com/hep/Fulltext/9…

Did you know that selective androgen receptor modulators, anabolic steroids and some body building supplements can cause #DILI ? Patients display cholestasis +/- pruritus. Tomorrow 11am EDT/8am PDT AASLD HepTox SIG is hosting Drs. Andrew Stolz and David Kleiner who will

New DILIN publication alert by esteemed Investigator Dr. Paul Watkins using blood-based transcriptomic biomarkers to aid in the diagnosis and prognosis of idiosyncratic #DILI pmc.ncbi.nlm.nih.gov/articles/PMC11…

What defines success in a Clinical Research Network? From the great Jay Hoofnagle at the #DILIN meeting - Elucidate pathogenesis of disease - Place findings in public domain - Stimulate research - Decrease morbidity and mortality of dz - Publications are not the end game